+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Antifungals Global Market Report 2021: COVID-19 Impact and Recovery to 2030

  • ID: 5319159
  • Report
  • April 2021
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Abbott Laboratories
  • Astellas Pharma Inc.
  • Bayer Healthcare
  • Glaxosmithkline Gilead
  • Kramer Laboratories
  • Merck & Co.
Antifungals Global Market Report 2021: COVID-19 Impact and Recovery to 2030 provides strategists, marketers and senior management with the critical information they need to assess the global antifungals market as it emerges from the COVID-19 shut down.







Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the antifungals? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Antifungals Market Global Report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:
1) By Drug Type: Echinocandins; Azoles; Polyenes; Allylamines
2) End users: Hospitals & Clinics; Dermatology clinics; Other Users
3) By Route of Administration: Oral; Parenteral; Topical
4) By Therapeutic Indications: Aspergillosis; Dermatophytosis; Candidiasis; Others

Companies Mentioned: Pfizer; Novartis; Merck & Co.; Bayer Healthcare; Abbott Laboratories

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Frequently Asked Questions about the Global Antifungals Market

What is the estimated value of the Global Antifungals Market?

The Global Antifungals Market was estimated to be valued at $10.3 billion in 2021.

What is the growth rate of the Global Antifungals Market?

The growth rate of the Global Antifungals Market is 7.4%, with an estimated value of $13.7 billion by 2025.

What is the forecasted size of the Global Antifungals Market?

The Global Antifungals Market is estimated to be worth $13.7 billion by 2025.

Who are the key companies in the Global Antifungals Market?

Key companies in the Global Antifungals Market include Pfizer, Novartis, Merck & Co., Bayer Healthcare, Abbott Laboratories, Sanofi, Aventis, Kramer Laboratories and Enzon Pharmaceuticals Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Astellas Pharma Inc.
  • Bayer Healthcare
  • Glaxosmithkline Gilead
  • Kramer Laboratories
  • Merck & Co.
1. Executive Summary

2. Antifungals Market Characteristics

3. Antifungals Market Trends And Strategies

4. Impact Of COVID-19 on Antifungals

5. Antifungals Market Size And Growth
5.1. Global Antifungals Historic Market, 2015-2020, $ Billion
5.1.1. Drivers of the Market
5.1.2. Restraints on The Market
5.2. Global Antifungals Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers of the Market
5.2.2. Restraints on the Market

6. Antifungals Market Segmentation
6.1. Global Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Echinocandins
  • Azoles
  • Polyenes
  • Allylamines
6.2. Global Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals & Clinics
  • Dermatology clinics
  • Other Users
6.3. Global Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oral
  • Parenteral
  • Topical
6.4. Global Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Aspergillosis
  • Dermatophytosis
  • Candidiasis
  • Others

7. Antifungals Market Regional And Country Analysis
7.1. Global Antifungals Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Antifungals Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Antifungals Market
8.1. Asia-Pacific Antifungals Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Antifungals Market
9.1. China Antifungals Market Overview
9.2. China Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Antifungals Market
10.1. India Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Antifungals Market
11.1. Japan Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Antifungals Market
12.1. Australia Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Antifungals Market
13.1. Indonesia Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Antifungals Market
14.1. South Korea Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Antifungals Market
15.1. Western Europe Antifungals Market Overview
15.2. Western Europe Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Antifungals Market
16.1. UK Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Antifungals Market
17.1. Germany Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Antifungals Market
18.4. France Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Antifungals Market
19.1. Eastern Europe Antifungals Market Overview
19.2. Eastern Europe Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Antifungals Market
20.1. Russia Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Antifungals Market
21.1. North America Antifungals Market Overview
21.2. North America Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Antifungals Market
22.1. USA Antifungals Market Overview
22.2. USA Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Antifungals Market
23.1. South America Antifungals Market Overview
23.2. South America Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Antifungals Market
24.1. Brazil Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Antifungals Market
25.1. Middle East Antifungals Market Overview
25.2. Middle East Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Antifungals Market
26.1. Africa Antifungals Market Overview
26.2. Africa Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Antifungals Market Competitive Landscape And Company Profiles
27.1. Antifungals Market Competitive Landscape
27.2. Antifungals Market Company Profiles
27.2.1. Pfizer
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Novartis
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Merck & Co.
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Bayer Healthcare
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Abbott Laboratories
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Antifungals Pipeline Analysis

29. Key Mergers And Acquisitions In The Antifungals Market

30. Antifungals Market Future Outlook and Potential Analysis

31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. About the Publisher
31.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Astellas Pharma Inc.
  • Bayer Healthcare
  • Glaxosmithkline Gilead
  • Kramer Laboratories
  • Merck & Co.
Major players in the antifungals market are Pfizer, Novartis, Merck & Co., Bayer Healthcare and Abbott Laboratories.

The global antifungals market is expected to grow from $9.98 billion in 2020 to $10.29 billion in 2021 at a compound annual growth rate (CAGR) of 3.1%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $13.71 billion in 2025 at a CAGR of 7.4%.

The antifungals market consists of sales of antifungal drugs which are used to detect and eliminate fungal pathogens. The fungal pathogens thrive in the body under unhygienic and unclean environments. These drugs are also known as an antimycotic medication, used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal meningitis, and others.

Drug developers and manufacturers are scaling up the various departments such as research and development, marketing, and manufacturing through collaborations and strategic partnerships with other companies and research institutes, to expand the product portfolios. So, companies in the anti-infective drugs market should consider strategic collaborations to broaden their scope and product portfolios to increase the revenues and stay competitive in the market.

A point prevalence survey was conducted in Turkey. According to the survey, antifungal drugs were mostly prescribed in pediatric hematology and oncology (PHO) units (35.2%), followed by neonatal ICUs (NICUs) (19.6%). The other units prescribing antifungal drugs included pediatric services (18.3%), pediatric ICUs (PICUs) (14.6%) and hematopoietic (HSCT) units (7.3%). According to the same survey, the antifungals were used for prophylaxis in 48.8% of patients and about 50% of patients were treated with antifungal drugs based on observation. Among 50% of patients, who were treated post observation, around 18.8% of patients were prescribed an antifungal therapy and 31.2% of patients were targeted for the treatments.

Antifungal drugs manufacturers are offering skimming price for branded drugs. The discovery, development and manufacturing processes of branded drugs generally require high investments. As a result, companies in the market offer the branded drugs at the highest initial prices, and implement other pricing strategies to ensure the product stays competitive at a high price. Price skimming is a pricing strategy in which a company charges a high initial price and then gradually lowers the price to attract more price-sensitive customers. It is used to maximize profits when a new product is introduced in the market. Manufacturers and marketers of branded drugs should consider adopting the price skimming strategy for branded drugs. They should price these branded drugs high to recover the high costs incurred during drug development and manufacturing.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Pfizer
  • Novartis
  • Merck & Co.
  • Bayer Healthcare
  • Abbott Laboratories
  • Sanofi-Aventis
  • Kramer Laboratories
  • Glaxosmithkline Gilead
  • Enzon Pharmaceuticals Inc.
  • Basilea Pharmaceutica AG
  • PerkinElmer
  • Alternaria
  • Sigma-Aldrich
  • Astellas Pharma Inc.
  • Janssen Pharmaceutica NV
  • Zydus Cadila Healthcare Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Sumitomo Dainippon Pharma Co. Ltd.
  • Scynexis Inc.
  • Mayne Pharma Inc.
  • Cosmo Pharmaceuticals NV
Note: Product cover images may vary from those shown

Loading
LOADING...